Moacyr Roberto Cucê Nobre

Economics, Econometrics and FinanceSocial SciencesMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Comparison of FDA accelerated vs regular pathway approvals for lung cancer treatments between 2006 and 2018”.

Comparison of FDA accelerated vs regular pathway approvals for lung cancer treatments between 2006 and 2018

PLoS ONE(2020)10.1371/journal.pone.0236345

N/A

0DataRank · unranked

19 citations

Lewis Buss, C. Wayant, Moacyr Roberto Cucê Nobre, Tatiane Bomfim Ribeiro